ERADICATE PATHOGENS AND SUBVERT FUTURE RESISTANCE
ALTABAX is a prescription topical antibacterial for impetigo that targets Staphylococcus aureus† and Streptococcus pyogenes in your patients.
*Retapamulin is bacteriostatic against Staphylococcus aureus and Streptococcus pyogenes. At concentrations 1,000 times the in vitro MIC, retapamulin is bactericidal against these same organisms.
Consumers
Get up to $15 off your prescription‡
Is Your Skin Infection Impetigo?
Take this simple test
‡ subject to eligibility
Important Safety Information
†ALTABAX is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
The most common drug-related adverse reaction was application site irritation (1.4% of patients).
Please see complete Prescribing Information for ALTABAX
- Kosowska-Shick K, Clark C, Credito K, et al. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother. 2006;50:765-769.
- Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol. 2008;158:1077-1082.
- Data on file ABX107, GlaxoSmithKline.



